Nom Nom vs Altria

Side-by-side comparison of AI visibility scores, market position, and capabilities

Altria leads in AI visibility (90 vs 36)

Nom Nom

EmergingPet Care

Pet Food

Mars-acquired fresh dog and cat food subscription with veterinary science and clinical trial validation; competing with The Farmer's Dog and Ollie for premium DTC pet food market through human-grade ingredients.

AI VisibilityBeta
Overall Score
D36
Category Rank
#6 of 6
AI Consensus
65%
Trend
stable
Per Platform
ChatGPT
29
Perplexity
31
Gemini
43

About

Nom Nom (formerly NomNomNow) is a Nashville-based fresh dog and cat food delivery subscription — acquired by Mars, Incorporated (private, the world's largest pet care company with $8B+ Pedigree/Whiskas/Royal Canin annual revenue) in 2023 — providing pet owners with human-grade, nutritionally balanced meals formulated by board-certified veterinary nutritionists and prepared fresh in USDA-inspected kitchens, delivered weekly or bi-weekly in pre-portioned meal packs calibrated to each pet's age, weight, breed, and health conditions.

Full profile

Altria

LeaderConsumer Goods

Enterprise

Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.

AI VisibilityBeta
Overall Score
A90
Category Rank
#83 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
97
Gemini
99

About

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.

Full profile

AI Visibility Head-to-Head

36
Overall Score
90
#6
Category Rank
#83
65
AI Consensus
58
stable
Trend
stable
29
ChatGPT
84
31
Perplexity
97
43
Gemini
99
36
Claude
86
30
Grok
87

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.